JPH05186357A - 飲食物消化分解産物吸収抑制手段 - Google Patents

飲食物消化分解産物吸収抑制手段

Info

Publication number
JPH05186357A
JPH05186357A JP3359568A JP35956891A JPH05186357A JP H05186357 A JPH05186357 A JP H05186357A JP 3359568 A JP3359568 A JP 3359568A JP 35956891 A JP35956891 A JP 35956891A JP H05186357 A JPH05186357 A JP H05186357A
Authority
JP
Japan
Prior art keywords
food
sodium polyacrylate
drink
drinking
aqueous liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3359568A
Other languages
English (en)
Japanese (ja)
Inventor
Shigeo Ochi
智 繁 夫 越
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP3359568A priority Critical patent/JPH05186357A/ja
Priority to CH3987/92A priority patent/CH684740A5/de
Priority to GB9227128A priority patent/GB2262888B/en
Priority to FR929215947A priority patent/FR2685611B1/fr
Priority to AU30455/92A priority patent/AU3045592A/en
Priority to CA002086566A priority patent/CA2086566A1/en
Priority to DE4244588A priority patent/DE4244588A1/de
Publication of JPH05186357A publication Critical patent/JPH05186357A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP3359568A 1991-12-31 1991-12-31 飲食物消化分解産物吸収抑制手段 Pending JPH05186357A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP3359568A JPH05186357A (ja) 1991-12-31 1991-12-31 飲食物消化分解産物吸収抑制手段
CH3987/92A CH684740A5 (de) 1991-12-31 1992-12-30 Absorptionsinhibitor für Verdauungs- und Zersetzungsprodukte von Nahrungsmitteln und Getränken.
GB9227128A GB2262888B (en) 1991-12-31 1992-12-30 Inhibitor for absorption of digested and decomposed products of food and drink
FR929215947A FR2685611B1 (fr) 1991-12-31 1992-12-30 Inhibiteur d'absorption de produits digeres et decomposes d'aliments et de boissons.
AU30455/92A AU3045592A (en) 1991-12-31 1992-12-30 Inhibitor for absorption of digested and decomposed products of food and drink
CA002086566A CA2086566A1 (en) 1991-12-31 1992-12-31 Inhibitor for absorption of digested and decomposed products of food and drink
DE4244588A DE4244588A1 (enExample) 1991-12-31 1992-12-31

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3359568A JPH05186357A (ja) 1991-12-31 1991-12-31 飲食物消化分解産物吸収抑制手段

Publications (1)

Publication Number Publication Date
JPH05186357A true JPH05186357A (ja) 1993-07-27

Family

ID=18465171

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3359568A Pending JPH05186357A (ja) 1991-12-31 1991-12-31 飲食物消化分解産物吸収抑制手段

Country Status (7)

Country Link
JP (1) JPH05186357A (enExample)
AU (1) AU3045592A (enExample)
CA (1) CA2086566A1 (enExample)
CH (1) CH684740A5 (enExample)
DE (1) DE4244588A1 (enExample)
FR (1) FR2685611B1 (enExample)
GB (1) GB2262888B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006522082A (ja) * 2003-04-05 2006-09-28 アストラゼネカ アクチボラグ 便秘症の処置または予防用のｉｂａｔ阻害剤の使用

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EG26979A (en) 2000-12-21 2015-03-01 Astrazeneca Ab Chemical compounds
GB0121337D0 (en) 2001-09-04 2001-10-24 Astrazeneca Ab Chemical compounds
GB0121622D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
GB0121621D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
MY131995A (en) 2001-09-08 2007-09-28 Astrazeneca Ab Benzothiazepine and benzothiadiazepine derivatives with illeal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
GB0209467D0 (en) 2002-04-25 2002-06-05 Astrazeneca Ab Chemical compounds
GB0213669D0 (en) 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0304194D0 (en) 2003-02-25 2003-03-26 Astrazeneca Ab Chemical compounds
AU2008202120B2 (en) * 2003-04-05 2009-12-17 Albireo Ab Use of an IBAT inhibitor for the treatment of prophylaxis of constipation
MX366925B (es) 2010-11-04 2019-07-31 Albireo Ab Inhibidores de ibat para el tratamiento de enfermedades hepaticas.
JO3301B1 (ar) 2013-04-26 2018-09-16 Albireo Ab تعديلات بلورية على إيلوبيكسيبات
CA2952406A1 (en) 2014-06-25 2015-12-30 Ea Pharma Co., Ltd. Solid formulation and method for preventing or reducing coloration thereof
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
JP6954927B2 (ja) 2016-02-09 2021-10-27 アルビレオ・アクチボラグ 経口コレスチラミン製剤及びその使用
CN108601744B (zh) 2016-02-09 2022-01-04 阿尔比里奥公司 口服考来烯胺制剂及其用途
CA3011595C (en) 2016-02-09 2024-01-02 Albireo Ab Cholestyramine pellets and methods for preparation thereof
CN111032019B (zh) 2017-08-09 2022-07-05 阿尔比里奥公司 考来烯胺颗粒、口服考来烯胺制剂及其用途
JP7391048B2 (ja) 2018-06-05 2023-12-04 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
KR20210024033A (ko) 2018-06-20 2021-03-04 알비레오 에이비 오데빅시바트의 약학 제제
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
SG11202108566VA (en) 2019-02-06 2021-09-29 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
CN113453753B (zh) 2019-02-06 2024-07-23 阿尔比里奥公司 苯并硫氮杂环庚三烯化合物及其用作胆汁酸调节剂的用途
JP7665621B2 (ja) 2019-12-04 2025-04-21 アルビレオ・アクチボラグ ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
WO2021110885A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
CA3158195A1 (en) 2019-12-04 2021-06-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
CN114786772B (zh) 2019-12-04 2024-04-09 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
ES3002777T3 (en) 2020-08-03 2025-03-07 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
AU2021379076A1 (en) 2020-11-12 2023-06-08 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
BR112023010799A2 (pt) 2020-12-04 2023-10-03 Albireo Ab Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares
CN117412955A (zh) 2021-06-03 2024-01-16 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2221139B1 (enExample) * 1973-03-13 1978-03-24 Nippon Kayaku Kk
DE3307816A1 (de) * 1983-03-02 1984-09-06 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin-haltiges pharmazeutisches praeparat und seine herstellung
GB8419245D0 (en) * 1984-07-27 1984-08-30 Reckitt & Colmann Prod Ltd Medicinal compositions
JPS61172815A (ja) * 1985-01-28 1986-08-04 Toshiyuki Nakajima 潤滑剤
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
GB8910076D0 (en) * 1989-05-03 1989-06-21 Thackray C F Ltd Sterilisable lubricant
JPH03120227A (ja) * 1989-10-02 1991-05-22 Shigeo Ochi 飲食物消化分解産物吸収抑制剤

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006522082A (ja) * 2003-04-05 2006-09-28 アストラゼネカ アクチボラグ 便秘症の処置または予防用のｉｂａｔ阻害剤の使用
JP2011173925A (ja) * 2003-04-05 2011-09-08 Albireo Ab 便秘症の処置または予防用のｉｂａｔ阻害剤の使用
JP4870552B2 (ja) * 2003-04-05 2012-02-08 アルビレオ・アクチボラグ 便秘症の処置または予防用のｉｂａｔ阻害剤の使用

Also Published As

Publication number Publication date
GB9227128D0 (en) 1993-02-24
GB2262888A (en) 1993-07-07
DE4244588A1 (enExample) 1993-07-15
CA2086566A1 (en) 1993-07-01
CH684740A5 (de) 1994-12-15
FR2685611A1 (fr) 1993-07-02
GB2262888B (en) 1996-07-24
AU3045592A (en) 1993-07-08
FR2685611B1 (fr) 1994-06-10

Similar Documents

Publication Publication Date Title
GB2262888A (en) Inhibitor for absorption of digested and decomosed products of food and drink
JP3850891B2 (ja) 緩下効果を有する組成物
US20100316768A1 (en) Nutritionally Fortified Liquid Composition With Added Value Delivery Systems/Elements/Additives
DE69630694T2 (de) Neutralisierung von sauren nahrungs- und arzneimitteln
JP2983503B2 (ja) 高い生物学的利用能をもつ鉄‐カルシウムミネラル補給物
IL151322A (en) Soluble fiber containing water
EP3137167A1 (en) Foods, systems, methods, and kits for providing electrolyte replacement
JP5414995B2 (ja) フコイダンを有効成分とする酸性尿改善飲食物および経口投与用医薬組成物
JPH05255097A (ja) 液状組成物
JPH0272843A (ja) 糖アルコールを含有するミネラル補給剤
Smith et al. Dietary concerns associated with the use of medications
JP3489095B2 (ja) 健康食品及び健康飲料
JP2000189109A (ja) 液状食品
EP2852298B1 (en) Composition for management of diabetes or pre-diabetes
JP3884611B2 (ja) 衝動性疾患の改善剤
Brophy et al. Clinical drug therapy for Canadian practice
US6506420B2 (en) Combinations of psyllium and chitosan for synergistic adsorption of triglyceride
WO2001091730A1 (en) Mineral supplement
JPH10306028A (ja) 脂質消化吸収阻害整腸剤
JP4460234B2 (ja) ダイエット食品
JPH06507393A (ja) 水溶性高粘度品位セルロースエーテルの薬剤組成物とその使用
JP2994594B2 (ja) 便秘用健康食品
US8993639B2 (en) Compound and method for treatment of gastroesophageal reflux
JP4435882B2 (ja) アルコール吸収抑制組成物
US20050214362A1 (en) Appetite suppressant